Cbx2 Antibody (3Z6W6)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-16164
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 3Z6W6
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 433-532 of human CBX2 (Q14781). GSATPSGQESRTAPGEARKAATLPEMSAGEESSSSDSDPDSASPPSTGQNPSVSVQTSQDWKPTRSLIEHVFVTDVTANLITVTVKESPTSVGFFNLRHY
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Cbx2 Antibody (3Z6W6)
Western Blot: Cbx2 Antibody (3Z6W6) [NBP3-16164]
Western Blot: Cbx2 Antibody (3Z6W6) [NBP3-16164] - Western blot analysis of extracts of various cell lines, using Cbx2 Rabbit mAb (NBP3-16164) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.Applications for Cbx2 Antibody (3Z6W6)
Application
Recommended Usage
Western Blot
1:500 - 1:2000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 0.05% BSA, 50% glycerol, pH7.3
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Cbx2
Long Name
Chromobox Homolog 2
Alternate Names
CDCA6, M33, SRXY5
Gene Symbol
CBX2
Additional Cbx2 Products
Product Documents for Cbx2 Antibody (3Z6W6)
Product Specific Notices for Cbx2 Antibody (3Z6W6)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...